NCT01962103 Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01942005 EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients Status COMPLETED Phase N/A
NCT01920061 A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) Status COMPLETED Phase PHASE1
NCT01794104 Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas Status COMPLETED Phase PHASE1
NCT01708850 Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2) Status COMPLETED Phase PHASE4
NCT01693172 Effect of an Early Mobilization Program on Outcomes After Major Cancer Surgery Status UNKNOWN Phase NA
NCT01517464 A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01457196 Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions Status COMPLETED Phase NA
NCT01425008 Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma Status COMPLETED Phase PHASE1
NCT01395407 Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain Metastases Status COMPLETED Phase PHASE1
NCT01287286 Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy Status UNKNOWN Phase PHASE2/PHASE3
NCT01287013 Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures Status TERMINATED Phase NA
NCT01163110 Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy Status COMPLETED Phase PHASE1
NCT01155713 Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01117623 Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01105533 A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors Status COMPLETED Phase PHASE1